Key result
Off-label thrombolysis for ischemic stroke resulted in symptomatic intracranial hemorrhage in 6.95% and extracranial hemorrhage in 6.22% of patients.
Why the study?
Does off-label thrombolysis cause excessive hemorrhagic complications in patients with ischemic stroke?
Systematic Review (n=273)
Does off-label thrombolysis cause excessive hemorrhagic complications in patients with ischemic stroke?
Answers are grounded in this paper and cite their sources.
The bleeding risk associated with off-label thrombolysis for ischemic stroke may not be as high as presumed, though a registry is needed to overcome reporting biases.
BACKGROUND AND PURPOSE: Only 2% to 4% of patients with acute ischemic stroke receive thrombolytic therapy resulting from the current strict inclusion criteria among other issues. Safety of intravenous and intraarterial thrombolysis in off-label situations is controversially discussed. We sought to review the reports on such patients regarding intra- and extracranial hemorrhage. SUMMARY OF REVIEW: A MEDLINE search for off-label uses of thrombolysis revealed reports on 273 patients treated with intraarterial or intravenous thrombolysis for ischemic stroke. Symptomatic intracranial hemorrhage occurred in 19 of 273 patients (6.95%) and extracranial hemorrhage in 17 of 273 (6.22%). CONCLUSIONS: These data suggest that the overall bleeding risk in off-label thrombolysis may not be as high as presumed. However, the small number of patients in each group and the likely underreporting of worse outcomes preclude drawing any conclusion as to specific treatment recommendations. Selected patients might benefit, however, from thrombolysis in situations not currently considered in the inclusion criteria. To obtain a meaningful database, a registry for off-label thrombolysis should be created.
No takes yet. Share an insight, caveat, or question.
Aleu et al. (2006) conducted a systematic review in Ischemic stroke (n=273). Off-label thrombolysis was evaluated on Symptomatic intracranial hemorrhage. Off-label thrombolysis for ischemic stroke resulted in symptomatic intracranial hemorrhage in 6.95% and extracranial hemorrhage in 6.22% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: